Engineering Inflammation-Resistant Cartilage: Bridging Gene Therapy and Tissue Engineering

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Orthopedics

Background:

• Articular cartilage defects often lead to post-traumatic osteoarthritis and rarely heal spontaneously.
• Current autologous cell therapies for cartilage injuries are limited by poor cell regeneration and joint inflammation.
• There is a need for advanced cartilage tissue engineering strategies resistant to inflammatory conditions.

Purpose of the Study:

• To engineer an inflammation-resistant cartilage tissue for enhanced regenerative potential.
• To investigate the protective effects of targeting the TGF-β-activated kinase 1 (TAK1) pathway in chondrocytes.
• To develop a novel therapeutic approach for articular cartilage repair.

Main Methods:

• Utilized CRISPR-Cas9 gene editing to knock out the TAK1 gene in polydactyly chondrocytes.
• Encapsulated TAK1-knockout (TAK1-KO) chondrocytes within a hyaluronan hydrogel.
• Evaluated the engineered cartilage's matrix deposition, integration, and in vivo immune response.

Main Results:

• TAK1-KO chondrocytes demonstrated multivalent protection against pro-inflammatory NF-κB pathway activation.
• Engineered cartilage secreted abundant extracellular matrix proteins and integrated well with native cartilage, even in inflammatory environments.
• In vivo implantation showed reduced M1 macrophage infiltration in TAK1-KO cartilage compared to wild-type (WT).

Conclusions:

• TAK1-KO polydactyly chondrocytes form a robust cartilage tissue resistant to inflammatory stimuli.
• This engineered cartilage exhibits reduced pro-inflammatory cytokine secretion, potentially mitigating immune responses.
• This study presents a paradigm shift in tissue engineering for potent and functional cartilage regeneration.